Dr. Dellon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Ste 313
Chapel Hill, NC 27517Phone+1 919-843-7200Fax+1 919-843-7136
Education & Training
- University of North Carolina HospitalsFellowship, Gastroenterology, 2004 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
- Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
- NC State Medical License 2004 - 2025
- MA State Medical License 2001 - 2004
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Start of enrollment: 2008 Jun 01
- Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) Start of enrollment: 2009 Oct 01
- Registry for Eosinophilic Gastrointestinal Disorders (REGID) Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHigh prevalence of eosinophilic gastrointestinal disorders in patients with atopic disease.Alexandra A Weir, Onyinye I Iweala, Evan S Dellon
Annals of Allergy, Asthma & Immunology. 2025-03-01 - Histologic Response or Endoscopic Normalization After Initial Treatment for Eosinophilic Esophagitis in Children Leads to Less Fibrostenosis over Long-Term Follow-Up.Hannah L Thel, Stephanie A Borinsky, Sean S LaFata, Timothy S Gee, Brenderia A Cameron
Digestive Diseases and Sciences. 2025-02-17 - Long-Term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: a 4-Year, Phase 3, Open-Label Study.Evan S Dellon, David A Katzka, Vincent A Mukkada, Margaret H Collins, Gary W Falk
Clinical Gastroenterology and Hepatology. 2025-02-13
Journal Articles
- Anti–Siglec-8 Antibody for Eosinophilic Gastritis and DuodenitisEvan S Dellon, Kathryn A Peterson, Gary W Falk, Nirmala Gonsalves, Michael Vaezi, Adam C Bledsoe, Alan T Chang, Ikuo Hirano, The New England Journal of Medicine
- RPC4046 in Patients with Eosinophilic EsophagitisEvan S Dellon, Ikuo Hirano, Clinical Gastroenterology and Hepatology
Authored Content
- RPC4046 in Patients with Eosinophilic EsophagitisMarch 2020
Press Mentions
- Guidance Developed for Diagnosis, Management of Eosinophilic EsophagitisJanuary 27th, 2025
- New ACG Guideline on EoE Reflects over a Decade of Advances in Diagnosis and ManagementJanuary 22nd, 2025
- AJG Special Issue on Inflammation Includes Updates ACG Guideline on Eosinophilic EsophagitisJanuary 17th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: